Ramosetron vs loperamide for bowel symptoms after rectal surgery
Part of Digestive system clinical trials.
This trial compares two medicines—ramosetron and loperamide—to see which works better for severe bowel control problems after low anterior rectal surgery. It may help people with major LARS (low anterior resection syndrome) choose a safer, more effective treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had mid or low rectal cancer surgery, with the tumor less than 15 cm from the anus
- Your cancer stage is II or III (not stage IV), and you had long-course chemoradiation before surgery
- You are currently about 1–12 months after the main surgery and about 1–6 months after the ileostomy repair (when the stoma was closed)
- You still have major LARS—ongoing severe bowel symptoms after surgery
- Your rectal cancer has not come back (no recurrence)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests two different types of enemas (antegrade and retrograde) to help manage bowel symptoms after rectal cancer surgery and to see if they can increase the rate of ileostomy reversal. If you had a temporary ileostomy after rectal cancer surgery and are planning to have it reversed soon, this study may help improve your bowel function.
This study tests whether a more intensive follow-up program after rectal cancer surgery can improve your recovery, daily function, and overall quality of life. If you've had a temporary ileostomy and are waiting for reversal, this extra support may help you feel better faster.
This study follows people with rectal cancer who have surgery to remove part of the rectum. It looks at how bowel function changes over time, and whether different treatments before surgery affect recovery.
This trial tests whether doing pelvic floor exercises after a type of rectal surgery called 'low anterior resection' can help prevent bowel problems known as Low Anterior Resection Syndrome (LARS). It may help you maintain better bowel control after surgery.
This trial tests a small, portable device called MiniGo that uses a gentle water rinse to help control bowel symptoms after rectal cancer surgery. It may be an option for people who still have bothersome bowel problems despite trying other treatments.
This trial studies how to improve bowel symptoms in people treated for rectal cancer. It tests personalized care plans and looks at different factors that may contribute to bowel problems after surgery or a watch-and-wait approach.
Hear when a new LARS - Low Anterior Resection Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.